• News
  • BioTech

FDA grants orphan designation to MEI Pharma investigational drug

MEI Pharma Inc., an oncology company based in San Diego, has been granted an orphan drug designation for the company's investigational drug Pracinostat by the U.S. Food and Drug Administration.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments

Subscribe Today!